ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,412Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 780

$1.02M Total Retail Price of All Prescriptions

Rank: 65 out of 780

438 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 13,764 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 907 592 1 3
SIMVASTATIN 702 540 2 2
LEVOTHYROXINE SODIUM 608 424 3 5
HYDROCODONE-ACETAMINOPHEN 538 455 S3 4 1
FUROSEMIDE 503 419 5 7
POTASSIUM CHLORIDE 431 342 6 11
LISINOPRIL 393 284 7 6
WARFARIN SODIUM 370 323 8 24
CITALOPRAM HBR 360 267 9 23
CARVEDILOL 343 252 10 14
TRAZODONE HCL 331 205 11 35
DONEPEZIL HCL 326 305 12 31
METOPROLOL SUCCINATE 288 207 13 20
GABAPENTIN 288 238 13 13
NAMENDA 286 261 15 46
PRAVASTATIN SODIUM 272 169 16 9
ADVAIR DISKUS 269 180 17 68
LOSARTAN POTASSIUM 267 186 18 18
AMLODIPINE BESYLATE 257 215 19 4
METFORMIN HCL ER 245 181 20 43
LEVOFLOXACIN 190 150 21 76
MELOXICAM 173 121 22 16
ROPINIROLE HCL 172 143 23 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 170 117 24 26
LANTUS 164 120 25 71
EXELON 155 136 26 132
GEMFIBROZIL 153 88 27 104
METOPROLOL TARTRATE 150 105 28 19
TAMSULOSIN HCL 148 120 29 36
FAMOTIDINE 136 104 30 86
ESCITALOPRAM OXALATE 135 107 31 61
CLONIDINE HCL 134 80 32 28
LOSARTAN-HYDROCHLOROTHIAZIDE 134 102 32 33
ISOSORBIDE MONONITRATE ER 130 123 34 60
TRAMADOL HCL 128 83 35 15
CRESTOR 127 56 36 32
QUETIAPINE FUMARATE 121 99 37 81
METFORMIN HCL 121 107 37 8
PREDNISONE 117 97 39 40
NEXIUM 117 71 39 22
PROAIR HFA 117 64 39 62
KLOR-CON M20 115 81 42 57
SINGULAIR 107 56 43 73
ALLOPURINOL 105 89 44 29
HYDROCHLOROTHIAZIDE 102 77 45 10
LEVETIRACETAM 100 29 46 130
KLOR-CON 10 100 77 46 90
LYRICA 100 93 46 52
ATENOLOL 99 75 49 21
DIVALPROEX SODIUM 97 73 50 119
ATORVASTATIN CALCIUM 94 65 51 12
INSULIN SYRINGE 91 54 52 80
BISOPROLOL-HYDROCHLOROTHIAZIDE 91 65 52 95
VENTOLIN HFA 91 57 52 91
SERTRALINE HCL 90 79 55 27
NOVOLOG 87 73 56 158
MIRTAZAPINE 86 86 57 58
CLOPIDOGREL 85 76 58 34
SPIRIVA 84 40 59 72
AMLODIPINE BESYLATE-BENAZEPRIL 84 71 59 50
ZETIA 82 47 61 94
POLYETHYLENE GLYCOL 3350 80 75 62 79
SPIRONOLACTONE 76 76 63 53
BUSPIRONE HCL 76 64 63 125
MONTELUKAST SODIUM 75 43 65 120
DILTIAZEM 24HR CD 74 69 66 138
JANUVIA 73 56 67 85
EVISTA 73 73 67 151
BENAZEPRIL HCL 73 50 67 59
DOXYCYCLINE HYCLATE 71 48 70 103
TRICOR 71 47 70 152
METOCLOPRAMIDE HCL 70 60 72 102
AMITRIPTYLINE HCL 68 41 R 73 48
CYMBALTA 67 53 74 51
JANUMET 64 36 75 208
TRAMADOL HCL-ACETAMINOPHEN 64 53 75 140
DIGOXIN 64 61 75 56
SUCRALFATE 62 50 78 149
CLOTRIMAZOLE-BETAMETHASONE 61 37 79 166
LEXAPRO 61 56 79 219
NOVOLOG MIX 70-30 59 48 81 328
VENLAFAXINE HCL ER 58 47 82 117
VESICARE 58 58 82 186
LANTUS SOLOSTAR 58 34 82 121
GLYBURIDE-METFORMIN HCL 57 41 R 85 108
SEROQUEL 57 49 85 172
ABILIFY 56 37 87 197
PANTOPRAZOLE SODIUM 55 41 88 25
FLUTICASONE PROPIONATE 55 44 88 41
IPRATROPIUM BROMIDE 54 48 90 238
ATROVENT HFA 54 40 90 432
FLUOXETINE HCL 52 35 92 65
ALBUTEROL SULFATE 51 46 93 163
ZOLPIDEM TARTRATE 50 38 94 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.